Structures by: Khalilov A. N.
Total: 25
2-Bromo-3-(3-<i>tert</i>-butyl-5-bromo-4-hydroxyphenyl)-3-methoxy-1-phenylpropan-1-one
C20H22Br2O3
Acta Crystallographica Section C (2019) 75, 3
a=9.6343(5)Å b=19.5472(10)Å c=10.9965(6)Å
α=90° β=91.584(2)° γ=90°
3-(3-<i>tert</i>-Butyl-5-chloro-4-hydroxyphenyl)-2-chloro-3-ethoxy-1-phenylpropan-1-one
C21H24Cl2O3
Acta Crystallographica Section C (2019) 75, 3
a=9.4460(13)Å b=19.783(3)Å c=11.0766(15)Å
α=90° β=93.821(3)° γ=90°
2-Bromo-3-(3-<i>tert</i>-butyl-5-bromo-4-hydroxyphenyl)-3-ethoxy-1-phenylpropan-1-one
C21H24Br2O3
Acta Crystallographica Section C (2019) 75, 3
a=9.6342(4)Å b=19.8082(8)Å c=11.1545(5)Å
α=90° β=94.0760(10)° γ=90°
(<i>E</i>)-3-[(4-Methylbenzylidene)amino]-5-phenylthiazolidin-2-iminium bromide <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C17H18N3S,Br,C3H7NO
Acta Crystallographica Section E (2020) 76, 10 1694-1698
a=8.4326(6)Å b=31.778(2)Å c=8.4680(6)Å
α=90° β=110.052(2)° γ=90°
1-(2-Fluorophenyl)-1<i>H</i>-tetrazole-5(4<i>H</i>)-thione
C7H5FN4S
Acta Crystallographica Section E (2020) 76, 7 1007-1011
a=23.5593(11)Å b=9.2849(5)Å c=7.7927(4)Å
α=90° β=104.0090(10)° γ=90°
(<i>E</i>)-5-Phenyl-3-[(pyridin-4-ylmethylidene)amino]thiazolidin-2-iminium bromide monohydrate
C15H15N4S,Br,H2O
Acta Crystallographica Section E (2018) 74, 9 1290-1294
a=5.8515(8)Å b=7.5304(10)Å c=18.859(3)Å
α=90° β=93.979(5)° γ=90°
3-Amino-5-phenylthiazolidin-2-iminium bromide
C9H12N3S,Br
Acta Crystallographica Section E (2019) 75, 10 1544-1547
a=10.5986(5)Å b=8.7168(3)Å c=13.0308(5)Å
α=90° β=111.513(2)° γ=90°
(<i>E</i>)-3-[(2,3-Dichlorobenzylidene)amino]-5-phenylthiazolidin-2-iminium bromide
C16H14Cl2N3S,Br
Acta Crystallographica Section E (2018) 74, 8 1168-1172
a=11.2586(8)Å b=6.8886(5)Å c=23.0145(16)Å
α=90° β=93.678(2)° γ=90°
(<i>E</i>)-3-[(4-Fluorobenzylidene)amino]-5-phenylthiazolidin-2-iminium bromide
C16H15F1N3S1,Br
Acta Crystallographica Section E (2019) 75, 5 662-666
a=8.0599(3)Å b=8.6086(4)Å c=12.7608(5)Å
α=96.548(2)° β=92.518(2)° γ=111.065(2)°
(<i>E</i>)-3-[(4-Chlorobenzylidene)amino]-5-phenylthiazolidin-2-iminium bromide
C16H15ClN3S,Br
Acta Crystallographica Section E (2019) 75, 8 1175-1179
a=8.3146(5)Å b=8.9424(5)Å c=12.2388(6)Å
α=80.988(2)° β=76.458(2)° γ=70.027(2)°
1-(Piperidin-1-yl)-3-(2,4,6-trimethylphenyl)propan-2-ol
C17H27NO
Acta Crystallographica Section E (2011) 67, 3 o739
a=11.7992(12)Å b=8.0940(8)Å c=17.0196(17)Å
α=90.00° β=107.4890(10)° γ=90.00°
4-(2,4,6-Trimethylbenzyl)-1,3-thiazol-2-amine
C13H16N2S
Acta Crystallographica Section E (2011) 67, 3 o721
a=5.5028(5)Å b=30.832(3)Å c=7.8355(7)Å
α=90.00° β=110.0160(10)° γ=90.00°
10-(2-Hydroxyethyl)-9-(2-hydroxyphenyl)-3,3,6,6-tetramethyl- 1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione
C25H31NO4
Acta Crystallographica Section E (2011) 67, 3 o744
a=9.7037(2)Å b=16.5123(3)Å c=13.8847(3)Å
α=90.00° β=102.132(3)° γ=90.00°
<i>N</i>-(4,6-Dimethylpyrimidin-2-yl)-1<i>H</i>-benzimidazol-2-amine
C13H13N5
Acta Crystallographica Section E (2011) 67, 3 o719
a=8.2836(4)Å b=9.6135(5)Å c=16.5694(8)Å
α=92.1210(10)° β=96.1000(10)° γ=112.5970(10)°
1-Methylamino-3-(2,4,6-trimethylphenyl)propan-2-ol
C13H21NO
Acta Crystallographica Section E (2011) 67, 4 o784
a=14.4080(10)Å b=5.8150(4)Å c=14.4503(10)Å
α=90.00° β=91.3710(10)° γ=90.00°
4a-Hydroxy-3,3,6,6-tetramethyl-9-[6-(3,3,6,6-tetramethyl-1,8-dioxo- 2,3,4,5,6,7,8,9-octahydro-1<i>H</i>-xanthen-9-yl)pyridin-2-yl]- 2,3,4,4a,5,6,7,8,9,9a-decahydro-1<i>H</i>-xanthene-1,8-dione ethanol hemisolvate hemihydrate
C39H47NO7,0.5(C2H6O),0.5(H2O)
Acta Crystallographica Section E (2011) 67, 4 o850-o851
a=14.9739(5)Å b=16.3416(4)Å c=15.3412(4)Å
α=90.00° β=101.113(3)° γ=90.00°
2,6-Di-<i>tert</i>-butyl-4-(3-chloro-2-hydroxypropyl)phenol
C17H27ClO2
Acta Crystallographica Section E (2011) 67, 4 o852
a=5.9536(3)Å b=19.4819(9)Å c=14.4310(7)Å
α=90.00° β=96.7980(10)° γ=90.00°
3-[2-Hydroxy-3-(2,4,6-trimethylphenyl)propyl]-3-methyl-1-phenylthiourea
C20H26N2OS
Acta Crystallographica Section E (2011) 67, 5 o1087
a=14.6313(11)Å b=8.1579(6)Å c=16.4455(12)Å
α=90.00° β=109.0400(10)° γ=90.00°
9-(5-Bromo-2-hydroxyphenyl)-10-(2-hydroxypropyl)-3,3,6,6-tetramethyl- 1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione
C26H32BrNO4
Acta Crystallographica Section E (2011) 67, 5 o1146
a=10.6685(4)Å b=16.8190(5)Å c=14.1260(5)Å
α=90.00° β=106.303(3)° γ=90.00°
Cyclohexane-1,1-dicarbonitrile
C8H10N2
Acta Crystallographica Section E (2011) 67, 7 o1801
a=8.9300(5)Å b=8.3656(5)Å c=9.8725(6)Å
α=90.00° β=92.6620(10)° γ=90.00°
4-[3-(Benzylamino)-2-hydroxypropyl]-2,6-di-<i>tert</i>-butylphenol
C24H35NO2
Acta Crystallographica Section E (2011) 67, 8 o2024
a=9.8053(10)Å b=18.870(2)Å c=23.584(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-Ethyl 2-cyano-3-(2,4-dimethoxyphenyl)prop-2-enoate
C14H15NO4
Acta Crystallographica Section E (2011) 67, 11 o2830
a=10.5661(6)Å b=6.9715(4)Å c=18.4141(10)Å
α=90.00° β=101.8580(10)° γ=90.00°
2-Anilino-3-(2-hydroxypropyl)-4-methyl-1,3-thiazol-3-ium chloride
C13H17N2OS,Cl
Acta Crystallographica Section E (2012) 68, 6 o1881-o1882
a=11.7570(4)Å b=12.2477(4)Å c=10.2954(3)Å
α=90° β=106.5320(10)° γ=90°
<i>N</i>-<i>tert</i>-Butyl-3-mesitylpropanamide
C16H25NO
Acta Crystallographica Section E (2011) 67, 6 o1307
a=12.8851(11)Å b=13.3441(11)Å c=9.4741(8)Å
α=90.00° β=106.540(2)° γ=90.00°
C68H64N6O12,4(CHCl3)
C68H64N6O12,4(CHCl3)
Journal of the American Chemical Society (2019)
a=9.3674(5)Å b=14.1728(7)Å c=15.4346(9)Å
α=102.300(3)° β=103.122(3)° γ=107.338(3)°